Latest filing published 18 Jan 2018 for CRISPR Therapeutics AG, €1.0M.
Filing timeline
BuySaleInsider track record
Tyler Dylan-Hyde: trading record in brief
Tyler Dylan-Hyde discloses dealings in CRISPR Therapeutics AG to SEC (Form 4). In total, 31 filings cover trades dated from 19 April 2017 to 16 January 2018.
Sales make up the whole of the open-market record (25 sales, €4.2M). The rest of the record consists of 6 option exercises. 2018 to date brings no purchases and 10 sales.
The latest filing, published on 18 January 2018, reports an open-market sale of €456k in CRISPR Therapeutics AG. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tyler Dylan-Hyde
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,000 shares@ US$28.0021.8% of flowCommon SharesSEC:0000899243-18-001348:0
- 1,110 shares@ US$12.570.2% of flowCommon SharesSEC:0000899243-18-001348:1
- 1,110 shares@ US$28.240.5% of flowCommon SharesSEC:0000899243-18-001348:2
- 19,890 shares@ US$12.574.3% of flowCommon SharesSEC:0000899243-18-001348:3
- 19,890 shares@ US$28.109.7% of flowCommon SharesSEC:0000899243-18-001348:4
- 30,000 shares@ US$20.5510.9% of flowCommon SharesSEC:0000899243-18-000520:0
- 8,000 shares@ US$12.571.8% of flowCommon SharesSEC:0000899243-18-000520:1
- 8,000 shares@ US$25.753.6% of flowCommon SharesSEC:0000899243-18-000520:2
- 700 shares@ US$14.430.2% of flowCommon SharesSEC:0000899243-18-000074:0
- 700 shares@ US$21.750.3% of flowCommon SharesSEC:0000899243-18-000074:1
- 6,230 shares@ US$14.431.6% of flowCommon SharesSEC:0000899243-18-000074:2
- 6,230 shares@ US$21.752.4% of flowCommon SharesSEC:0000899243-18-000074:3
- 9,070 shares@ US$12.572.0% of flowCommon SharesSEC:0000899243-18-000074:4
- 1,070 shares@ US$21.750.4% of flowCommon SharesSEC:0000899243-18-000074:5
- 8,000 shares@ US$23.763.4% of flowCommon SharesSEC:0000899243-18-000074:6
- 15,000 shares@ US$22.686.1% of flowCommon SharesSEC:0000899243-18-000074:7
- 15,000 shares@ US$20.555.5% of flowCommon SharesSEC:0000899243-17-029619:0
- 15,000 shares@ US$18.905.1% of flowCommon SharesSEC:0000899243-17-029163:0
- 477 shares@ US$18.550.2% of flowCommon SharesSEC:0000899243-17-019847:0
- 13,210 shares@ US$18.564.4% of flowCommon SharesSEC:0000899243-17-019847:1
- 1,313 shares@ US$18.600.4% of flowCommon SharesSEC:0000899243-17-019847:2
- 1,852 shares@ US$16.610.6% of flowCommon SharesSEC:0000899243-17-011672:0
- 3,200 shares@ US$16.761.0% of flowCommon SharesSEC:0000899243-17-011230:0
- 13,527 shares@ US$16.844.5% of flowCommon SharesSEC:0000899243-17-011230:1
- 4,912 shares@ US$16.621.6% of flowCommon SharesSEC:0000899243-17-011230:2
25 of 31 declarations
